☐
|
| |
Preliminary Proxy Statement
|
☐
|
| |
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
☒
|
| |
Definitive Proxy Statement
|
☐
|
| |
Definitive Additional Materials
|
☐
|
| |
Soliciting Material Pursuant to Sec.240.14a-12
|
|
(Name of Registrant as Specified In Its Charter)
|
Not Applicable
|
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
|
☒
|
| |
No fee required.
|
|||
☐
|
| |
Fee paid previously with preliminary materials.
|
|||
☐
|
| |
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
![]() |
| |
Meeting Date:
June 7, 2023
|
| |
![]() |
| |
Meeting Place:
555 12th Street NW
Suite 700
Washington, D.C. 20004
|
| |
![]() |
| |
Meeting Time:
9:30 a.m. (EDT)
|
| |
![]() |
| |
Record Date:
March 9, 2023
|
|
| |
|
| |
|
||||||
|
| |
PROPOSAL NUMBER
|
| |
PROPOSAL
|
| |
BOARD OF DIRECTORS
VOTING
RECOMMENDATION
|
| |
|
| |
No. 1
|
| |
Consider and vote upon the election as directors of the nine nominees named in the Proxy Statement
|
| |
FOR each nominee
|
| |
|
|
| |
No. 2
|
| |
Consider and vote upon the ratification of the appointment of KPMG LLP as FTI Consulting, Inc.’s
independent registered public accounting firm for the year ending December 31, 2023
|
| |
FOR
|
| | ||
| |
No. 3
|
| |
Consider and vote upon an advisory (non-binding) resolution to approve the compensation of the named
executive officers for the year ended December 31, 2022 as described in the Proxy Statement
|
| |
FOR
|
| |
|
|
| |
No. 4
|
| |
Consider and vote on the frequency of advisory (non-binding) votes on executive compensation of our
named executive officers
|
| |
FOR ONE YEAR
|
| | ||
| |
|
| |
The transaction of any other business that may properly come before the meeting or any postponement
or adjournment thereof
|
| |
N/A
|
| |
|
|
| |
Postponements and Adjournments:
|
| |
Any action on the items of business described above may be considered at the meeting, at the time and
on the date specified above or at any time and date to which the meeting may be properly postponed or adjourned.
|
| ||||||
| |
In-Person Meeting Admission:
|
| |
Admission will be by ticket only. Please follow the advance registration instructions set forth in
the section of the Proxy Statement titled “Information about the Annual Meeting and Voting — How Do I Attend the Annual Meeting?” on page 5 of the Proxy Statement. If you do not provide an admission ticket and comply with the photo identification requirements outlined on page 5, you will not be admitted to the 2023 annual meeting. Cameras, recording devices and other electronic devices will not be permitted at the 2023 annual meeting.
|
| |
|
||||
| |
Voting:
|
| |
YOUR VOTE IS VERY IMPORTANT. Whether or not
you plan to attend the meeting, we hope you will authorize a proxy to vote on your behalf as soon as possible. For specific instructions on how to authorize a proxy to vote your shares, please refer to the section titled “Information
about the Annual Meeting and Voting” beginning on page 2 of the Proxy Statement. Make sure to have your proxy
card or voting instruction form in hand to authorize a proxy to vote your shares. You may vote or authorize a proxy to vote your shares as follows:
|
|
![]() |
| |
In person at the
Annual Meeting
|
| |
![]() |
| |
By telephone at
+1.800.690.6903
|
| |
![]() |
| |
Over the Internet at
www.proxyvote.com
|
| |
![]() |
| |
By mailing your
completed proxy card in
the envelope provided
|
By Order of the Board of Directors,
![]() Joanne F. Catanese
Associate General Counsel and Corporate Secretary
April 24, 2023
|
|
Important Notice Regarding the Availability of Proxy Materials for the Annual
Meeting of Shareholders to Be Held on June 7, 2023 (the “Annual Meeting”): We mailed a Notice of Internet Availability of Proxy Materials containing instructions on how to access our Proxy Statement for
the Annual Meeting and our 2022 Annual Report on or about April 24, 2023. Our Proxy Statement and Annual Report are available online at www.proxyvote.com.
|
|
|
Date:
|
| |
June 7, 2023
|
|
|
Time:
|
| |
9:30 a.m., Eastern Daylight Time
|
|
|
Location:
|
| |
FTI Consulting, Inc.
555 12th Street NW
Suite 700
Washington, D.C. 20004
|
|
|
Record Date:
|
| |
Close of business on March 9, 2023
|
|
|
Stock Symbol:
|
| |
FCN
|
|
|
Exchange:
|
| |
New York Stock Exchange (the “NYSE”)
|
|
|
Common Stock Outstanding as of the Close of Business on the Record Date Entitled
to Vote at the Annual Meeting:
|
| |
33,983,032 shares of common stock, par value $0.01 per share (“Common Stock”)
|
|
|
Registrar and Transfer Agent:
|
| |
American Stock Transfer & Trust Company
|
|
|
State of Incorporation:
|
| |
Maryland
|
|
|
Year of Incorporation:
|
| |
1982
|
|
|
Public Company Since:
|
| |
1996
|
|
|
Corporate Website:
|
| |
www.fticonsulting.com
|
|
(1)
|
See Appendix A for the definitions of earnings per diluted share (“EPS”), as adjusted (“Adjusted EPS”), and other financial measures for financial reporting purposes referred to in this Proxy Statement, which have not been
presented or prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) that are considered not in conformity with GAAP (“non-GAAP”), and the reconciliations of non-GAAP financial measures to the
most directly comparable GAAP financial measures. Certain of these non-GAAP financial measures are not defined the same as the similarly named financial measures used to establish annual incentive pay (“AIP”) for the year ended
December 31, 2022 (“2022 AIP”). See the section of this Proxy Statement titled “Information about our Executive Officers and Compensation — Compensation Discussion and Analysis — 2022 Pay Outcomes — 2022 Annual Incentive Pay — Financial
Metrics” beginning on page 55 and Appendix B for the definitions of similarly named non-GAAP financial measures for determining 2022 AIP of our named executive officers (“NEO”) and the reconciliations of such non-GAAP financial measures to the most
directly comparable GAAP financial measures.
|
(1)
|
See Appendix A for the definitions of EBITDA, as adjusted (“Adjusted EBITDA”), Adjusted EPS, organic revenue growth and other non-GAAP financial measures for financial reporting purposes referred to in this Proxy Statement and
the reconciliations of non-GAAP financial measures to the most directly comparable GAAP financial measures. Certain of these non-GAAP financial measures are not defined the same as the similarly named financial measures used to
establish AIP. See “Information about Our Executive Officers and Compensation — Compensation Discussion & Analysis — 2022 Pay Outcomes — 2022 Annual Incentive Pay — Financial Metrics” beginning on page 55 and Appendix B for the definitions of similarly
named financial measures for determining 2022 AIP of our NEOs and the reconciliations of such non-GAAP financial measures to the most directly comparable GAAP financial measures.
|
(1)
|
“Per employee” refers to FTI Consulting’s total employee headcount (excluding independent contractors),
as reported in our Annual Report on Form 10-K for reconciliations of “employees, including independent contractors,” to “employees, excluding independent contractors,” for the applicable calendar year ended December 31, for each
applicable calendar year ended December 31 plus independent contractors as of December 31 of the applicable calendar year ended December 31. “Independent contractors” are defined as temporary resources who at times may travel on behalf
of FTI Consulting for business purposes. See Appendix C.
|
(2)
|
2019 is representative of pre-COVID-19-pandemic in-office attendance, business travel and printer usage,
as these emissions were repressed in both 2020 and 2021 due to COVID-19-related restrictions on business travel and office occupancy.
|
(3)
|
“Sustainably disposed of” refers to information technology equipment that was recycled or remarketed in
an environmentally friendly manner during the years ended December 31, 2021 and December 31, 2022.
|
(1)
|
“Employees” refers to FTI Consulting’s total headcount as reported in our Annual Reports on Form 10-K
for each calendar year ended December 31.
|
(1)
|
Employee engagement statistics are based on employee responses to the Company’s 2022 Great Place to
Work® survey.
|
—
|
Employees logged more than 79,000 training hours.
|
—
|
Averaged 11 training hours per employee.
|
| | | | |
|
| ||
| | |
Annual Cash
Base Salary
|
| |
Fixed element of annual compensation.
Annual cash base salary of each NEO (other than
the Chief Executive Officer (“CEO”)) increased from $600,000 in 2021 to $700,000 in 2022.
|
| |
| | |
AIP Program
|
| |
Short-term cash incentive with variable payout opportunities based on Adjusted EPS, Adjusted EBITDA
and individual performance measured against annual performance goals.
No changes to AIP performance measures and
target values of AIP as a multiple of annual cash base salary payout opportunities for 2022.
|
| |
| | |
Long-Term Incentive Pay (“LTIP”) Program
|
| |
Long-term equity incentives in the forms of time-based award of shares of restricted stock (“RSA”)
and performance-based award of restricted stock units (“Performance RSU”) with multi-year vesting schedules.
No changes to LTIP performance measure and form
of payout. Target LTIP opportunity for our CEO increased from 4.5x annual cash base salary for 2021 to 6.0x annual cash base salary for 2022. Target LTIP payment opportunity as a multiple of annual cash base salary for the other NEOs
did not change for 2022.
|
| |
| | | | |
|
|
|
2022 CEO’s Compensation at Target
|
| |
2022 Other NEOs’ Compensation at Target
|
|
|
![]() |
| |
![]() |
|
![]() |
| |
Fall
Informed by our summer report,
we extend an invitation to our 20 largest shareholders to assess corporate governance and compensation trends and practices that are important to them.
Winter
Report shareholder feedback
from our fall meetings to the Board and use shareholder feedback to enhance our proxy disclosure and make appropriate changes to our governance practices and executive compensation program.
Spring
Conduct follow-up conversations
with our largest shareholders and extend an invitation to our 20 largest shareholders to discuss important issues that will be considered at our upcoming annual meeting.
Summer
Prepare a report for the Board
that includes a review of voting results and feedback we received from our shareholders during the proxy season. This discussion informs outreach and engagement plans for our meetings with shareholders during the fall.
|
89%
Independent
Directors
|
| |
33%
Female
Directors
|
| |
22%
Racially Diverse
Directors
|
| |
9 Years
Average Tenure
(Range: 0 - 19 years)
|
| |
65
Average Age
|
| |
33%
Directors Based
Outside of U.S.
|
|
| |
|
| |
|
||||||||||||||||||
|
| |
|
| |
COMMITTEE MEMBERSHIP
|
| |
|
|||||||||||||||
|
| |
DIRECTOR NOMINEES
|
| |
AGE
|
| |
DIRECTOR
SINCE
|
| |
INDEPENDENT
|
| |
AUDIT
|
| |
COMPENSATION
|
| |
NOMINATING,
CORPORATE
GOVERNANCE AND
SOCIAL
RESPONSIBILITY
|
| |
|
| |
Gerard E. Holthaus
Lead Independent Director of
WillScot Mobile Mini Holdings Corp.
|
| |
73
|
| |
2004
|
| |
![]() |
| |
•
|
| |
•
|
| |
|
| |
|
|
| |
Steven H. Gunby
President and Chief Executive
Officer of
FTI Consulting, Inc.
|
| |
65
|
| |
2014
|
| | | | | | | | | | ||||||
| |
Brenda J. Bacon
President and Chief Executive
Officer of Brandywine Senior Living LLC
|
| |
72
|
| |
2006
|
| |
✔
|
| |
|
| |
•
|
| |
C
|
| |
|
|
| |
Mark S. Bartlett
Retired Partner at Ernst &
Young LLP
|
| |
72
|
| |
2015
|
| |
✔
|
| |
•
|
| | | | | | ||||
| |
Elsy Boglioli (1)
Chief Executive Officer of
Bio-Up
|
| |
41
|
| |
2023
|
| |
✔
|
| |
|
| |
|
| |
|
| |
|
|
| |
Claudio Costamagna
Chairman of CC e Soci S.r.l.
|
| |
67
|
| |
2012
|
| |
✔
|
| | | |
C
|
| | | | ||||
| |
Nicholas C. Fanandakis
Retired Chief Financial Officer
of Dupont de Nemours, Inc.
|
| |
66
|
| |
2014
|
| |
✔
|
| |
C
|
| |
|
| |
|
| |
|
|
| |
Stephen C. Robinson
Retired Partner of the Law Firm
of Skadden, Arps, Slate, Meagher & Flom LLP
|
| |
66
|
| |
2022
|
| |
✔
|
| | | | | |
•
|
| | ||||
| |
Laureen E. Seeger
Chief Legal Officer of the
American Express Company
|
| |
61
|
| |
2016
|
| |
✔
|
| |
|
| |
•
|
| |
•
|
| |
|
(1)
|
On April 6, 2023, the Board took action, and effective on April 7, 2023, the size of the Board was
increased to ten directors from nine directors and the Board elected Elsy Boglioli as a director to fill the vacancy on the Board resulting from such action. The Board has not taken action to elect Ms. Boglioli to any Committee.
|
![]() |
Independent Chairman of the Board
|
C
|
Committee Chair
|
|
PROPOSAL NUMBER
|
| |
PROPOSAL
|
| |
BOARD OF
DIRECTORS VOTING RECOMMENDATION
|
|
|
No. 1
|
| |
Consider and vote upon the election as directors of the nine nominees named in the Proxy Statement
|
| |
FOR each nominee
|
|
|
Each of the nine directors has been nominated by the Board to stand for election as a director of the
Company. Each nominee, if elected, will serve as a director for a term until the next annual meeting of shareholders and until his or her successor is duly elected and qualifies or until his or her death, resignation, retirement or
removal (whichever occurs earliest). (See page 12.)
|
| ||||||
|
No. 2
|
| |
Consider and vote upon the ratification of the appointment of KPMG LLP as FTI
Consulting, Inc.’s independent registered public accounting firm for the year ending December 31, 2023
|
| |
FOR
|
|
|
Our Audit Committee has appointed KPMG LLP (“KPMG”) as the independent registered public accounting
firm to audit our books and records for the year ending December 31, 2023. KPMG has acted as our auditor since 2006. We are offering shareholders the opportunity to ratify the appointment of our independent registered public accounting
firm as a matter of good corporate governance practice. (See page 32.)
|
| ||||||
|
No. 3
|
| |
Consider and vote upon an advisory (non-binding) resolution to approve the
compensation of the named executive officers for the year ended December 31, 2022 as described in the Proxy Statement
|
| |
FOR
|
|
|
In accordance with applicable law and the preference of our shareholders to cast an advisory
(non-binding) vote on say-on-pay every year, we are affording our shareholders the opportunity to cast an advisory (non-binding) vote to approve the following resolution:
|
| ||||||
|
“RESOLVED, that the shareholders approve, on an advisory (non-binding) basis, the compensation of the Company’s named
executive officers for the year ended December 31, 2022 as described in the Proxy Statement for the 2023 Annual Meeting of Shareholders.”
|
| ||||||
|
No. 4
|
| |
Consider and conduct an advisory (non-binding) vote on the frequency of
advisory (non-binding) votes on executive compensation of our named executive officers
|
| |
FOR ONE YEAR
|
|
|
In accordance with applicable law, shareholders are being afforded the opportunity to cast an
advisory (non-binding) vote on how often we should hold advisory (non-binding) votes on executive compensation of our named executive officers in the future. The frequency options are to hold the advisory (non-binding) votes to approve
the executive compensation of our named executive officers every one year, every two years or every three years. We currently afford shareholders the opportunity to submit an advisory (non-binding) vote on executive compensation of our
named executive officers every year. (See page 35.)
|
| ||||||
| | |
The transaction of any other business that may properly come before the
meeting or any postponement or adjournment thereof
|
| |
N/A
|
|
|
Proposal No. 1: Elect as
directors the nine nominees named in the Proxy Statement
|
| |
As there are nine nominees for the nine director seats up for election, each nominee will be elected
as a director if he or she receives the affirmative vote of a majority of the total votes cast “FOR” and “AGAINST” with respect to his or her election as a director at the Annual Meeting. Any abstentions or broker non-votes are not
counted as votes cast either “FOR” or “AGAINST” with respect to a director’s election and will have no effect on the election of directors.
The Board recommends a vote FOR the election of each nominee as a
director.
|
|
|
Proposal No. 2: Ratify the
appointment of KPMG LLP (“KPMG”) as FTI Consulting, Inc.’s independent registered public accounting firm for the year ending December 31, 2023
|
| |
Ratification of the appointment of KPMG as the Company’s independent registered public accounting
firm for the year ending December 31, 2023 requires a majority of the votes cast on the proposal at the Annual Meeting to be voted “FOR” this proposal. Abstentions will not count as votes cast either “FOR” or “AGAINST” Proposal No. 2 and
will have no effect on the results of the vote on this proposal. We do not anticipate any broker non-votes for this proposal.
The Board recommends a vote FOR the ratification of the appointment
of KPMG.
|
|
|
Proposal No. 3: Vote on an
advisory (non-binding) resolution to approve the compensation of the named executive officers for the year ended December 31, 2022 as described in the Proxy Statement
|
| |
The approval of an advisory resolution approving the compensation of our named executive officers for
the year ended December 31, 2022 as described in this Proxy Statement for the Annual Meeting requires a majority of the votes cast on this proposal at the Annual Meeting to be voted “FOR” this proposal. Abstentions and broker non-votes
will not be counted as votes cast either “FOR” or “AGAINST” Proposal No. 3 and will have no effect on this proposal. However, this proposal is an advisory (non-binding) proposal.
The Board recommends a vote FOR the advisory (non-binding)
resolution to approve the compensation of our named executive officers for the year ended December 31, 2022 as described in this Proxy Statement.
|
|
|
Proposal No. 4: Advisory
(non-binding) vote on the frequency of advisory (non-binding) votes on executive compensation of our named executive officers
|
| |
A majority of the votes cast for Proposal No. 4 will determine the shareholders’ preferred frequency
for holding advisory (non-binding) votes on executive compensation of our named executive officers. This means that the option for holding advisory votes every one year, every two years, or every three years, receiving a majority of the
votes cast on Proposal No. 4 will be considered the preferred frequency of the shareholders. In the event that no option receives a majority of the votes cast, we will consider the option receiving the most votes to be the option selected
by shareholders. Any abstentions or broker non-votes will not be counted as votes cast with respect to Proposal No. 4, and will have no effect on the results of the vote on this proposal.
The Board recommends a vote to hold advisory (non-binding) votes on
named executive officer compensation every one year.
|
|
|
| |
|
| |
|
|||||||||||||||||||||||||||||||||
|
| |
DIRECTOR NOMINEES
|
| |
LEADERSHIP
|
| |
FINANCE
AND
ACCOUNTING
|
| |
SERVICES
OR
INDUSTRY
|
| |
GOVERNMENT
|
| |
OTHER
PUBLIC
COMPANY
BOARD
EXPERIENCE
|
| |
GLOBAL
|
| |
GENDER
DIVERSITY
|
| |
RACIAL
DIVERSITY
|
| |
CYBERSECURITY
|
| |
INDEPENDENCE
|
| |
|
|||
| |
![]() |
| |
Brenda J. Bacon
|
| |
•
|
| |
•
|
| |
•
|
| |
•
|
| |
•
|
| |
|
| |
•
|
| |
•
|
| |
|
| |
•
|
| |
|
|
| |
![]() |
| |
Mark S. Bartlett
|
| |
•
|
| |
•
|
| |
•
|
| | | |
•
|
| |
•
|
| | | | | | | |
•
|
| | ||||||
| |
![]() |
| |
Elsy Boglioli
|
| |
•
|
| |
|
| |
•
|
| |
|
| |
•
|
| |
•
|
| |
•
|
| |
|
| |
|
| |
•
|
| |
|
|
| |
![]() |
| |
Claudio Costamagna
|
| |
•
|
| |
•
|
| |
•
|
| | | |
•
|
| |
•
|
| | | | | | | |
•
|
| | ||||||
| |
![]() |
| |
Nicholas C. Fanandakis
|
| |
•
|
| |
•
|
| |
•
|
| |
|
| |
•
|
| |
•
|
| |
|
| |
|
| |
(1)
|
| |
•
|
| |
|
|
| |
|
| |
|
|||||||||||||||||||||||||||||||||
|
| |
DIRECTOR NOMINEES
|
| |
LEADERSHIP
|
| |
FINANCE
AND
ACCOUNTING
|
| |
SERVICES
OR
INDUSTRY
|
| |
GOVERNMENT
|
| |
OTHER
PUBLIC
COMPANY
BOARD
EXPERIENCE
|
| |
GLOBAL
|
| |
GENDER
DIVERSITY
|
| |
RACIAL
DIVERSITY
|
| |
CYBERSECURITY
|
| |
INDEPENDENCE
|
| |
|
|||
| |
![]() |
| |
Steven H. Gunby
|
| |
•
|
| |
•
|
| |
•
|
| | | |
•
|
| |
•
|
| | | | | | | | | | |||||||
| |
![]() |
| |
Gerard E. Holthaus
|
| |
•
|
| |
•
|
| |
•
|
| |
|
| |
•
|
| |
•
|
| |
|
| |
|
| |
|
| |
•
|
| |
|
|
| |
![]() |
| |
Stephen C. Robinson
|
| |
•
|
| | | |
•
|
| |
•
|
| |
•
|
| | | | | |
•
|
| | | |
•
|
| | ||||||
| |
![]() |
| |
Laureen E. Seeger
|
| |
•
|
| |
|
| |
•
|
| |
|
| |
•
|
| |
•
|
| |
•
|
| |
|
| |
|
| |
•
|
| |
|
(1)
|
Mr. Fanandakis received the CERT Certificate in Cybersecurity Oversight in 2023 from the Software
Engineering Institute of Carnegie Mellon University.
|
89%
Independent
Directors
|
| |
33%
Female
Directors
|
| |
22%
Racially Diverse
Directors
|
| |
9 Years
Average Tenure
(Range: 0 - 19 years)
|
| |
65
Average Age
|
| |
33%
Directors Based
Outside of U.S.
|
|
2023 DIRECTOR NOMINEES
|
| |||
|
Brenda J. Bacon
|
| |
Steven H. Gunby
|
|
|
Mark S. Bartlett
|
| |
Gerard E. Holthaus
|
|
|
Elsy Boglioli
|
| |
Stephen C. Robinson
|
|
|
Claudio Costamagna
|
| |
Laureen E. Seeger
|
|
|
Nicholas C. Fanandakis
|
| |
|
|
|
2023
NOMINEES FOR DIRECTOR
|
| |
PRINCIPAL OCCUPATION AND BUSINESS EXPERIENCE
|
|
|
![]() Independent Director
Director Since: 2006
Age: 72
|
| |
Brenda J. Bacon has been the President and Chief Executive Officer of Brandywine Senior Living LLC
since July 2004. Ms. Bacon co-founded Brandywine Living in 1996. Brandywine Senior Living LLC currently has 31 operating properties in seven states, with additional communities in development. Brandywine Senior Living LLC is a growing
platform for luxury senior living with supportive services. Ms. Bacon served as Chief of Management and Planning, a cabinet-level position for the State of New Jersey, under former New Jersey Governor James J. Florio from 1989 to 1993.
During President William J. Clinton’s first term, Ms. Bacon was on loan to the Presidential Transition Team as co-chair for the transition of the Department of Health and Human Services.
Current Other Public Company Directorships and
Committees:
Hilton Grand Vacations Inc. [Member of Audit Committee and Nominating and Corporate Governance
Committee]
Select Current Non-Public Directorships and
Committees:
Argentum [Director]
Rowan University [Trustee] [Member of University Advancement Committee]
|
|
|
![]() Independent Director
Director Since: 2015
Age: 72
|
| |
Mark S. Bartlett has extensive accounting and financial services experience, having retired as a
Partner of Ernst & Young LLP, a leading accounting firm, in June 2012. Mr. Bartlett joined Ernst & Young LLP in 1972 and worked there until his retirement, serving as Managing Partner of the firm’s Baltimore office and Senior
Client Service Partner for the Mid-Atlantic region. He is a certified public accountant.
Current Other Public Company Directorships and
Committees:
T. Rowe Price Group, Inc. [Chair of Audit Committee and Member of Executive Compensation and
Management Development Committee]
WillScot Mobile Mini Holdings Corp. [Chair of Audit Committee and Member of Compensation Committee]
Zurn Elkay Water Solutions Corporation [Lead Independent Director] [Member of Audit Committee and
Executive Committee]
|
|
|
2023
NOMINEES FOR DIRECTOR
|
| |
PRINCIPAL OCCUPATION AND BUSINESS EXPERIENCE
|
|
|
![]() Independent Director
Director Since: 2023
Age: 41
|
| |
Elsy Boglioli is the founder and has been Chief Executive Officer of Bio-Up, a consulting firm
providing advisory services to companies in the healthcare technology field, since September 2019. From December 2017 to August 2019, Ms. Boglioli was Executive Vice President and Chief Operating Officer of Cellectis, a clinical-stage
biopharmaceutical company focusing on cell therapies. Ms. Boglioli has extensive experience in the consulting services industry, having been employed by the Boston Consulting Group, a leading business strategy consulting services firm,
from January 2006 to November 2017, holding various positions, including Partner and Managing Director and leader of its biotech-focused business in Europe, and serving as a member of its global Strategy and Biopharma Practice leadership
teams.
Current Foreign Public Company Directorships and
Committees:
GenSight Biologics S.A. [Chair of the Nomination Committee]
OSE Immunotherapeutics SA [Member of the Nomination and Remuneration Committee]
Select Current Foreign Non-Public Directorships:
Treefrog Therapeutics [Chair]
Inova.io
Laverock Therapeutics
Metafora Biosystems.
Womed Tech
|
|
|
![]() Independent Director
Director Since: 2012
Age: 67
|
| |
Claudio Costamagna is Chairman of CC e Soci S.r.l., a financial advisory firm he founded in June
2007, and CC Holdings S.r.L., its parent. Mr. Costamagna has extensive experience in investment banking, having served for 18 years, until April 2006, in various positions with The Goldman Sachs Group, Inc., culminating as Chairman of the
Investment Banking Division in Europe, the Middle East and Africa from December 2004 to March 2006.
Select Past Foreign Public Company Directorships:
REVO S.p.A [Chairman]
Advanced Accelerator Applications S.A. [Chairman]
Cassa Depositi e Prestiti [Chairman]
Select Current Foreign Non-Public Directorships:
CC e Soci S.r.l. [Chairman]
Ferragamo Finanziaria S.p.A.
Finavedi S.p.A.
Italiana Petroli S.p.A.
Salini Costruttori S.p.A.
|
|
|
2023
NOMINEES FOR DIRECTOR
|
| |
PRINCIPAL OCCUPATION AND BUSINESS EXPERIENCE
|
|
|
![]() Independent Director
Director Since: 2014
Age: 66
|
| |
Nicholas C. Fanandakis served as Senior Adviser to the Chief Executive Officer of DuPont de Nemours,
Inc. (“DuPont”), a leading global research and technology-based science company, from February 2020 to December 2020. In June 2019, Mr. Fanandakis retired as an Executive Vice President of DuPont after 40 years of service. Mr. Fanandakis
helped lead the company through the merger with The Dow Chemical Company, and then subsequent separations. From November 2009 to June 2019, Mr. Fanandakis served as Chief Financial Officer and Executive Vice President of DuPont and led
the company through major portfolio transformations. Mr. Fanandakis joined DuPont in 1979 as an accounting and business analyst. Since then, he has served in a variety of plant, marketing, product management and business director roles.
Mr. Fanandakis served as Group Vice President of DuPont Applied BioSciences from 2008 to 2009. Mr. Fanandakis also served as Vice President and General Manager of DuPont Chemical Solutions Enterprise from 2003 until February 2007, when he
was named Vice President of DuPont Corporate Plans.
Mr. Fanandakis received the CERT Certificate in Cybersecurity Oversight in 2023 from the Software
Engineering Institute of Carnegie Mellon University.
Current Other Public Company Directorships and
Committees:
Duke Energy Corp. [Member of Audit Committee and Finance and Risk Management Committee]
ITT Inc. [Member of Audit Committee and Compensation and Personnel Committee]
|
|
|
![]() Director Since: 2014
Age: 65
|
| |
Steven H. Gunby joined the Company as its President and Chief Executive Officer on January 20, 2014.
Mr. Gunby has extensive experience in the consulting services industry, having formerly been employed by The Boston Consulting Group, a leading business strategy consulting services firm, for more than 30 years, beginning in August 1983.
The positions he held with The Boston Consulting Group include Global Leader, Transformation, from January 2011 to January 2014, and Chairman, North and South America, from December 2003 to December 2009. He also held other major
managerial roles in his capacity as a Senior Partner and Managing Director since 1993, including serving as a member of The Boston Consulting Group’s Executive Committee.
Current Other Public Company Directorships and
Committees:
Arrow Electronics, Inc. [Chair of Compensation Committee]
|
|
|
2023
NOMINEES FOR DIRECTOR
|
| |
PRINCIPAL OCCUPATION AND BUSINESS EXPERIENCE
|
|
|
![]() Independent Director
Chairman of the Board Since: 2013
Director Since: 2004
Age: 73
|
| |
Gerard E. Holthaus has served as the Lead independent Director of WillScot Mobile Mini Holdings
Corp., a leading provider of modular space solutions in North America since July 2020. Mr. Holthaus served as independent non-executive Chairman of the Board of Directors of WillScot Corp. from November 2017 up to and until the merger of
Mobile Mini Corp. into WillScot Corp. in July 2020. Prior to November 2017, Mr. Holthaus served as non-executive Chairman of the Board of Directors of Algeco Scotsman Global S.a.r.l. and its holding company, Algeco/Scotsman Holdings
S.a.r.l., a leading global provider of modular space solutions, positions that he held since April 2010. From October 2007 to April 2010, Mr. Holthaus held the positions of Executive Chairman of the Board of Directors and Chief Executive
Officer of Algeco Scotsman Global S.a.r.l.
Current Other Public Company Directorships and
Committees:
WillScot Mobile Mini Holdings Corp. [Lead Independent Director] [Member of Audit Committee and Chair
of Nominating and Corporate Governance Committee]
Select Past Public Company Directorships:
Algeco Scotsman Global S.a.r.l.
BakerCorp International, Inc.
Neff Corporation
Nesco Holdings, Inc.
Select Current Non-Public Directorships and
Committees:
Loyola University Maryland [Chairman]
Saint Joseph Hospital [Chairman of the Board]
The Baltimore Life Companies [Chairman of the Board] [Member of Nominating and Corporate Governance
Committee]
|
|
|
![]() Independent Director
Director Since: 2022
Age: 66
|
| |
Stephen C. Robinson is a retired partner of the law firm of Skadden, Arps, Slate, Meagher & Flom
LLP (“Skadden”), a multinational law firm. Mr. Robinson joined Skadden in 2010 practicing in its litigation department, with a focus on government enforcement and white-collar crime until his retirement in 2021. Mr. Robinson previously
served as a U.S. District Judge for the U.S. District Court for the Southern District of New York from 2003 to 2010, for which he was nominated by President George W. Bush. Prior to serving on the Southern District court, Mr. Robinson
held several other positions in government. From 1998 to 2001, he served as a U.S. Attorney for the District of Connecticut, for which he was nominated by President William J. Clinton. From 1993 to 1995, he served as Principal Deputy
General Counsel for the Federal Bureau of Investigation. Mr. Robinson has also served in multiple leadership and management roles, including as the Chief Executive Officer of Empower New Haven, a non-profit agency focused on urban
development social services, from 2002 to 2003, and as the Chief Compliance Officer of Aetna U.S. Healthcare, a managed healthcare company, from 1996 to 1998.
Current Other Public Company Directorships and
Committees:
Dycom Industries, Inc. [Member of Audit Committee and Finance Committee]
Select Current Non-Public Directorships and
Committees:
Cornell University [Trustee]
Lincoln Center for the Performing Arts [Trustee]
The New York Community Trust [Trustee]
Weill Cornell Medicine [Fellow]
|
|
|
2023
NOMINEES FOR DIRECTOR
|
| |
PRINCIPAL OCCUPATION AND BUSINESS EXPERIENCE
|
|
|
![]() Independent Director
Director Since: 2016
Age: 61
|
| |
Laureen E. Seeger is Chief Legal Officer of the American Express Company, a diversified financial
services company, having previously held the title of Executive Vice President and General Counsel from July 2014 to July 2018. From March 2006 through June 2014, Ms. Seeger served as Executive Vice President, General Counsel and Chief
Compliance Officer at McKesson Corporation, a global diversified healthcare services company, where she led the Law, Public Affairs, Compliance and Corporate Secretary functions, while guiding the company through complex legal and
regulatory environments and contributing to its financial growth. Ms. Seeger joined McKesson in 2000 as General Counsel of its Technology Division. In this role, she provided leadership through complex merger and acquisition transactions
and product evolutions while building the Law Department and enhancing client service.
Select Current Non-Public Directorships and
Committees:
Central Park Conservancy [Trustee]
University of Wisconsin Foundation and Alumni Association [Chair of Governance Committee]
|
|
|
|
| |
BOARD OF DIRECTORS
|
| |
AUDIT COMMITTEE
|
| |
COMPENSATION
COMMITTEE
|
| |
NOMINATING, CORPORATE
GOVERNANCE AND SOCIAL
RESPONSIBILITY COMMITTEE
|
|
|
Total Meetings Held
|
| |
8
|
| |
6
|
| |
6
|
| |
4
|
|
|
NAME (1)
|
| |
AUDIT
|
| |
COMPENSATION
|
| |
NOMINATING, CORPORATE
GOVERNANCE AND SOCIAL
RESPONSIBILITY
|
|
|
Brenda J. Bacon
|
| |
|
| |
•
|
| |
Chair
|
|
|
Mark S. Bartlett
|
| |
•
|
| | | | | ||
|
Claudio Costamagna
|
| |
|
| |
Chair
|
| |
|
|
|
Vernon Ellis (2)
|
| |
•
|
| | | |
•
|
| |
|
Nicholas C. Fanandakis
|
| |
Chair
|
| |
|
| |
|
|
|
Gerard E. Holthaus
|
| |
•
|
| |
•
|
| | | |
|
Stephen C. Robinson
|
| |
|
| |
|
| |
•
|
|
|
Laureen E. Seeger
|
| | | |
•
|
| |
•
|
|
(1)
|
On April 6, 2023, the Board took action, and effective on April 7, 2023, the size of the Board was
increased to ten directors from nine directors and the Board elected Elsy Boglioli as a director to fill the vacancy on the Board resulting from such action. The Board has not taken action to elect Ms. Boglioli to any Committee.
|
(2)
|
Vernon Ellis will remain a member of the Audit Committee and Nominating, Corporate Governance and Social
Responsibility Committee until the Annual Meeting.
|
|
COMMITTEE
|
| |
WEBSITE LINK
|
|
|
Audit Committee
|
| |
https://www.fticonsulting.com/~/media/Files/us-files/our-firm/guidelines/charter-of-the-
audit committee-of-the-board-of-directors.pdf
|
|
|
Compensation Committee
|
| |
https://www.fticonsulting.com/~/media/Files/us-files/our-firm/guidelines/charter-of-the-
compensation-committee-of-the-board-of-directors.pdf
|
|
|
Nominating, Corporate Governance and Social Responsibility Committee
|
| |
https://www.fticonsulting.com/-/media/files/us-files/our-firm/guidelines/charter-of-the-
nominating-corporate-governance-and-social-responsibility-committee-of-the-board.pdf
|
|
|
■
|
| |
selects, oversees and retains our independent registered public accounting
firm;
|
|
|
■
|
| |
reviews and discusses the scope of the annual audit and written
communications by our independent registered public accounting firm to the Audit Committee and management;
|
|
|
■
|
| |
oversees our financial reporting activities, including the annual audit and
the accounting standards and principles we follow;
|
|
|
■
|
| |
approves audit and non-audit services by our independent registered public
accounting firm and applicable fees;
|
|
|
■
|
| |
reviews and discusses our periodic reports filed with the SEC;
|
|
|
■
|
| |
reviews and discusses our earnings press releases and communications with
financial analysts and investors;
|
|
|
■
|
| |
oversees our internal audit activities;
|
|
|
■
|
| |
oversees our disclosure controls and procedures;
|
|
|
■
|
| |
reviews Section 404 of the Sarbanes-Oxley Act of 2002, internal control over
financial reporting;
|
|
|
■
|
| |
oversees and monitors our Policy on Reporting Concerns and Non-Retaliation
and related reports;
|
|
|
■
|
| |
reviews and discusses risk assessment and risk management policies and
practices, including risks associated with cybersecurity- and climate-related matters;
|
|
|
■
|
| |
oversees the administration of the Code of Ethics and Business Conduct and
other ethics policies;
|
|
|
■
|
| |
reviews, discusses and approves insider and affiliated person transactions;
|
|
|
■
|
| |
administers the policy with respect to the hiring of former employees of the
Company’s independent registered public accounting firm;
|
|
|
■
|
| |
performs an annual self-evaluation of the Audit Committee;
|
|
|
■
|
| |
reviews the Audit Committee Charter and recommends changes to the Nominating,
Corporate Governance and Social Responsibility Committee for submission to the Board for approval; and
|
|
|
■
|
| |
prepares the Audit Committee Report required to be included in the annual
proxy statement.
|
|
|
■
|
| |
approves the compensation of our CEO;
|
|
|
■
|
| |
administers our equity-based compensation plans and approves awards under
such plans;
|
|
|
■
|
| |
establishes objective performance goals, individual award levels, and
operative and subjective performance measures and oversees all aspects of executive officer incentive compensation;
|
|
|
■
|
| |
reviews and approves, or recommends that the Board approve, employment,
consulting and other contracts or arrangements with present and former executive officers;
|
|
|
■
|
| |
reviews the compensation disclosures in the annual proxy statement and Annual
Report on Form 10-K filed with the SEC and discusses the disclosures with management;
|
|
|
■
|
| |
performs annual performance evaluations of our CEO and reviews the CEO’s
annual performance evaluations of other executive officers, in conjunction with the independent Chairman of the Board or other presiding director, as applicable, and Chair of the Nominating, Corporate Governance and Social Responsibility
Committee;
|
|
|
■
|
| |
performs an annual self-evaluation of the Compensation Committee;
|
|
|
■
|
| |
reviews the Compensation Committee Charter and recommends changes to the
Nominating, Corporate Governance and Social Responsibility Committee for submission to the Board for approval;
|
|
|
■
|
| |
prepares the Compensation Committee Report included in the annual proxy
statement;
|
|
|
■
|
| |
submits all equity-based compensation plans, executive officer compensation
plans and material revisions to such plans to a vote of the Board and to a vote of shareholders if shareholder approval is required; and
|
|
|
■
|
| |
ensures that shareholders have the opportunity to vote on (i) an advisory
(non-binding) resolution to approve the compensation of the Company’s NEOs and (ii) the frequency of the shareholder advisory (non-binding) votes to approve the resolution approving the compensation of the NEOs at least once every six
years.
|
|
|
■
|
| |
identifies and qualifies the annual slate of directors for nomination by the
Board;
|
|
|
■
|
| |
reviews non-employee director compensation and recommends changes to the
Board for approval;
|
|
|
■
|
| |
assesses the independence of directors for the Board;
|
|
|
■
|
| |
identifies and qualifies the candidates for Chairman of the Board and for
membership and chairmanship of the Committees for appointment by the Board;
|
|
|
■
|
| |
identifies and qualifies candidates to fill vacancies occurring between
annual meetings of shareholders for election by the Board;
|
|
|
■
|
| |
monitors compliance with, and reviews proposed changes to, our Corporate
Governance Guidelines, the Committee Charters, and other policies and practices relating to corporate governance for submission to the Board for approval;
|
|
|
■
|
| |
monitors and reviews responses to shareholder communications with
non-management directors together with the independent Chairman of the Board or presiding director, as applicable;
|
|
|
■
|
| |
oversees the process for director education;
|
|
|
■
|
| |
oversees the process for Board and Committee annual self-evaluations;
|
|
|
■
|
| |
oversees the process for performance evaluations of our executive officers in
conjunction with our independent Chairman of the Board and the Compensation Committee;
|
|
|
■
|
| |
oversees the process relating to succession planning for our CEO and other
executive officer positions;
|
|
|
■
|
| |
reviews directors’ and officers’ liability insurance terms and limits;
|
|
|
■
|
| |
oversees, and reports to the Board and other interested Committees, regarding
social responsibility, human capital and ESG- and other sustainability-related factors;
|
|
|
■
|
| |
reviews and discusses with management the Company’s reports that address
ESG-related topics;
|
|
|
■
|
| |
reviews the Nominating, Corporate Governance and Social Responsibility
Committee Charter and recommends changes to the Board for approval;
|
|
|
■
|
| |
reviews the annual proxy statement disclosures, including those pertaining to
the nomination of directors, the election of directors, the independence of directors, corporate governance and ESG; and
|
|
|
■
|
| |
performs an annual self-evaluation of the Nominating, Corporate Governance
and Social Responsibility Committee.
|
|
|
| |
|
| |
|
||||||
|
| |
COMPENSATION ELEMENTS
|
| |
2022 DIRECTOR COMPENSATION VALUES (1) (5)
($)
|
| |
ALTERNATIVE FORMS OF PAYMENT
|
| |
|
| |
Annual Retainer: (2) (5) (6)
|
| |
50,000
|
| |
Cash or Deferred Stock Units
|
| |
|
|
| |
Annual Committee Chair Fees: (2) (5)
|
| |
10,000 — Chair of Audit Committee
7,500 — Chair of Compensation Committee
5,000 — Chair of Nominating, Corporate
Governance and Social Responsibility Committee |
| |
Cash or Deferred Stock Units
|
| | ||
| |
Additional Annual Non-Employee
Chairman of the Board Fee: (2) (5)
|
| |
200,000
|
| |
Cash or Deferred Stock Units
|
| |
|
|
| |
Annual Equity Award: (2) (3) (4) (5) (6)
|
| |
250,000
|
| |
Restricted Stock, Restricted Stock Units,
Deferred Restricted Stock Units or Cash
|
| |
(1)
|
Continuing non-employee directors receive payment of the annual retainer and annual equity award, and
Chairman of the Board or Committee Chair fee, if applicable, as of the date of each annual meeting of shareholders. A new non-employee director receives a prorated annual retainer and equity award upon first being elected to the Board
other than at an annual meeting. A non-employee director, who is appointed as a Chair other than following an annual meeting, receives a prorated non-executive Chairman of the Board or Committee Chair fee, as applicable.
|
(2)
|
U.S. non-employee directors are permitted to voluntarily defer annual retainer payments (including any
annual fee to the non-executive Chairman of the Board or a Committee Chair) and/or annual equity compensation awards in the form of deferred stock units or deferred restricted stock units, respectively. Deferred stock units awarded on
account of deferred annual retainer and Chairman of the Board or Committee Chair fees are vested in full on the grant date. Deferred restricted stock units granted on account of deferred annual equity compensation awards vest in full on
the first anniversary of the grant date unless vesting is accelerated as described in footnote (4) below. Each deferred stock unit and deferred restricted stock unit represents the right to receive one share of Common Stock upon the
earliest of (i) a separation from service event, (ii) an elected payment date, and (iii) certain other permissible payment events, in each case, in accordance with Section 409A (“Code Section 409A”) of the U.S. Internal Revenue Code of
1986, as amended (the “Internal Revenue Code”).
|
(3)
|
The annual equity award, unless deferred, is in the form of shares of restricted stock, in the case of
U.S. non-employee directors, and restricted stock units, in the case of non-U.S. non-employee directors. Each restricted stock unit represents the right to receive one share of Common Stock upon vesting. Annual equity awards are
non-transferable and vest in full on the first anniversary of the grant date unless vesting is accelerated as described in footnote (4) below.
|
(4)
|
All unvested shares of restricted stock and restricted stock units will immediately vest in full upon a
non-employee director’s (i) death, (ii) “Disability” (as defined in the Director Plan), (iii) cessation of service within one year following a Change in Control unless other accommodations are made with respect to such awards,
(iv) cessation of service at the expiration of his or her term as a director due to the Company’s failure to renominate such director for service on the Board (other than for “Cause” (as determined by the Board, in its good-faith
discretion), due to the request of such director or as a result of a voluntary resignation) or (v) cessation of service due to failure of the Company’s shareholders to elect such director for service on the Board (other than for “Cause”
(as determined by the Board, in its good-faith discretion).
|
(5)
|
The number of (i) deferred stock units awarded to a non-employee director as annual retainer
compensation (including any annual fee to the non-executive Chairman of the Board or a Committee Chair) and (ii) shares of restricted stock, restricted stock units and deferred restricted stock units awarded to a non-employee director
as annual equity compensation will be determined by dividing (a) the U.S. dollar value of such award by (b) the closing price per share of Common Stock reported on the NYSE for the grant date. Fractional restricted shares, restricted
stock units, deferred stock units and deferred restricted share units are rounded down to the nearest whole share.
|
(6)
|
If we do not have sufficient shares of Common Stock authorized under our shareholder-approved equity
compensation plan to fund annual retainer and equity awards in stock-based awards, such awards will be funded in cash. The payout of such cash amounts will be subject to the terms of the applicable deferred compensation payment and
vesting and accelerated vesting conditions, including the requirements of Code Section 409A of the Internal Revenue Code. Such cash amounts generally will accrue interest at the rate of 6% per annum.
|
|
NAME
|
| |
ANNUAL
RETAINER AND
CHAIR FEE
EARNED OR
PAID IN CASH
($)
(A)
|
| |
STOCK
AWARDS (1)
($)
(B)
|
| |
OPTION
AWARDS (1)
($)
(C)
|
| |
ALL OTHER
COMPENSATION (2)
($)
(D)
|
| |
TOTAL
($)
(E)
|
|
|
2022 Non-Employee Directors:
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
|
Brenda J. Bacon
|
| |
55,000
|
| |
249,955
|
| |
—
|
| |
—
|
| |
304,955
|
|
|
Mark S. Bartlett
|
| |
50,000
|
| |
249,955
|
| |
—
|
| |
—
|
| |
299,955
|
|
|
Claudio Costamagna
|
| |
57,500
|
| |
249,955
|
| |
—
|
| |
—
|
| |
307,455
|
|
|
Vernon Ellis
|
| |
50,000
|
| |
249,955
|
| |
—
|
| |
—
|
| |
299,955
|
|
|
Nicholas C. Fanandakis
|
| |
60,000
|
| |
249,955
|
| |
—
|
| |
—
|
| |
309,955
|
|
|
Gerard E. Holthaus
|
| |
250,000
|
| |
249,955
|
| |
—
|
| |
—
|
| |
499,955
|
|
|
Stephen C. Robinson (3)
|
| |
59,863
|
| |
299,121
|
| |
—
|
| |
—
|
| |
358,984
|
|
|
Laureen E. Seeger
|
| |
—
|
| |
299,879
|
| |
—
|
| |
—
|
| |
299,879
|
|
|
2022 Former Non-Employee Director:
|
| | | | | | | | | | | |||||
|
Nicole S. Jones (4)
|
| |
9,863
|
| |
299,121
|
| |
—
|
| |
—
|
| |
308,984
|
|
(1)
|
The balances of each non-employee director’s equity-based awards as of December 31, 2022 (excluding
vested shares of Common Stock) are set forth in the table below:
|
|
| |
|
| |
|
||||||||||||
|
| |
NAME
|
| |
UNVESTED RESTRICTED
SHARES OR RESTRICTED
STOCK UNITS
|
| |
VESTED DEFERRED
STOCK OR DEFERRED
RESTRICTED
STOCK UNITS
|
| |
UNVESTED DEFERRED
STOCK OR DEFERRED
RESTRICTED
STOCK UNITS
|
| |
UNEXERCISED
STOCK OPTIONS
|
| |
|
| |
2022 Non-Employee Directors:
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
| |
Brenda J. Bacon
|
| |
1,492
|
| |
—
|
| |
—
|
| |
—
|
| | ||
| |
Mark S. Bartlett
|
| |
1,492
|
| |
—
|
| |
—
|
| |
—
|
| |
|
|
| |
Claudio Costamagna
|
| |
1,492
|
| |
—
|
| |
—
|
| |
—
|
| | ||
| |
Vernon Ellis
|
| |
1,492
|
| |
—
|
| |
—
|
| |
—
|
| |
|
|
| |
Nicholas C. Fanandakis
|
| |
—
|
| |
—
|
| |
1,492
|
| |
—
|
| | ||
| |
Gerard E. Holthaus
|
| |
1,492
|
| |
37,500
|
| |
—
|
| |
—
|
| |
|
|
| |
Stephen C. Robinson (3)
|
| |
1,809
|
| |
—
|
| |
—
|
| |
—
|
| | ||
| |
Laureen E. Seeger
|
| |
—
|
| |
2,515
|
| |
1,492
|
| |
—
|
| |
|
|
| |
2022 Former Non-Employee Director:
|
| | | | | | | | ||||||||
| |
Nicole S. Jones (4)
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
|
(2)
|
No current director received perquisites or other benefits aggregating more than $10,000 in 2022.
|
(3)
|
Mr. Robinson’s compensation includes the prorated annual cash retainer of $9,863 and restricted stock
compensation with a grant date value of $49,166.70 awarded to him on March 22, 2022 upon his first election to the Board.
|
(4)
|
Ms. Jones resigned as a director of the Company and member of the Compensation Committee effective on
October 14, 2022, due to obligations arising from her position as Executive Vice President and General Counsel of The Cigna Group (formerly Cigna Corporation) that resulted in scheduling conflicts and limited the time she was able to
devote to her position as a director of the Company. Upon her resignation, Ms. Jones forfeited all unvested shares of restricted stock awarded to her on March 22, 2022 and June 1, 2022 with grant date values of $49,166.70 and
$249,954.76, respectively. In addition, Ms. Jones returned to the Company the annual cash retainer in the amount of $50,000 paid upon her election to the Board at the 2022 Annual Meeting.
|
|
NAME OF POLICY
|
| |
WEBSITE LINK
|
|
|
Standards of Director Independence
|
| |
https://www.fticonsulting.com/~/media/Files/us-files/our-firm/guidelines/categorical-standards-
for-director-independence.pdf
|
|
|
Corporate Governance Guidelines
|
| |
https://www.fticonsulting.com/~/media/Files/us-files/our-firm/guidelines/fti-consulting-corporate-
governance-guidelines.pdf
|
|
|
Code of Ethics and Business Conduct
|
| |
https://www.fticonsulting.com/~/media/Files/us-files/our-firm/guidelines/fti-code-of-conduct.pdf
|
|
|
Anti-Corruption Policy
|
| |
https://www.fticonsulting.com/~/media/Files/us-files/our-firm/guidelines/anti-corruption-policy.pdf
|
|
|
Policy on Reporting Concerns and Non-Retaliation
|
| |
https://www.fticonsulting.com/~/media/Files/us-files/our-firm/guidelines/policy-on-reporting-
concerns-and-non-retaliation.pdf
|
|
|
Policy on Disclosure Controls
|
| |
https://www.fticonsulting.com/~/media/Files/us-files/our-firm/guidelines/policy-on-disclosure-
controls.pdf
|
|
|
Policy on Inside Information and Insider Trading
|
| |
https://www.fticonsulting.com/~/media/Files/us-files/our-firm/guidelines/policy-statement-on-
inside-information-and-insider-trading.pdf
|
|
|
■
|
| |
Annual Director Elections. Shareholders elect our directors annually to hold office until the next annual meeting of shareholders and until his or her successor is duly elected and qualifies or until his or her death, resignation, retirement or removal
(whichever occurs earliest).
|
|
|
■
|
| |
Non-Employee Independent Chairman of the Board. Gerard E. Holthaus is our non-employee independent Chairman of the Board. More information about our Chairman of the Board may be found in the section titled “— Board Leadership Structure” on page 27 of this Proxy Statement.
|
|
|
■
|
| |
Majority Voting in Uncontested Director Elections. A nominee in an uncontested election shall be elected as a director only if such nominee receives the affirmative vote of a majority of the total votes cast “FOR” and “AGAINST” as to such nominee at a
meeting. Any abstentions or broker non-votes are not counted as votes cast either “FOR” or “AGAINST” with respect to a director’s election and will have no effect on the election of directors.
|
|
|
■
|
| |
Director Resignation.
Our Corporate Governance Guidelines provide that in an uncontested election, if an incumbent director fails to receive the required majority vote, he or she must offer to resign from the Board. The Nominating, Corporate Governance and
Social Responsibility Committee will (a) consider such offer to resign, (b) determine whether to accept such director’s resignation, and (c) submit such recommendation for consideration by the Board. The director whose offer to resign
is under consideration may not participate in any deliberation or vote of the Nominating, Corporate Governance and Social Responsibility Committee or the Board regarding his or her offer of resignation. In the event that all directors
offer to resign in accordance with our resignation policy, the Nominating, Corporate Governance and Social Responsibility Committee will make
|
|
|
|
| |
a final determination as to whether to recommend to the Board to accept all offers to resign,
including those offers made by members of the Nominating, Corporate Governance and Social Responsibility Committee. The Nominating, Corporate Governance and Social Responsibility Committee and the Board may consider any factors they deem
relevant in deciding whether to accept a director’s offer to resign. Within 90 days after the date of certification of the election results, the Board will publicly disclose the Board’s decision of whether or not to accept an offer of
resignation. If such incumbent director’s offer to resign is not accepted by the Board, such director will continue to serve until his or her successor is duly elected and qualifies or until his or her death, resignation, retirement or
removal (whichever occurs earliest). If a director’s offer to resign is accepted by the Board, then the Board, in its sole discretion, may fill any resulting vacancy pursuant to the Company’s Bylaws or reduce the size of the Board.
|
|
|
■
|
| |
Executive Sessions. Our
Board meets regularly in executive sessions, without the presence of management, including our CEO.
|
|
|
■
|
| |
Shareholder Rights Plan.
We do not have a shareholder rights plan and are not currently considering adopting one.
|
|
|
■
|
| |
Shareholder Power to Amend Bylaws. Our shareholders, by the affirmative vote of the holders of a majority of the shares of Common Stock entitled to vote, have the power to adopt, alter or repeal any Bylaw of the Company.
|
|
|
NAME OF POLICY
|
| |
WEBSITE LINK
|
|
|
Environmental Responsibility & Climate Change Disclosure Policy
|
| |
https://www.fticonsulting.com/~/media/Files/us-files/our-firm/guidelines/fti-consulting-
environmental-climate-change-disclosure-policy.pdf
|
|
|
Global Health & Safety Policy
|
| |
https://www.fticonsulting.com/~/media/Files/us-files/our-firm/guidelines/fti-consulting-global-
health-safety-policy.pdf
|
|
|
Human Rights Policy
|
| |
https://www.fticonsulting.com/~/media/Files/us-files/our-firm/guidelines/fti-consulting-human-
rights-policy.pdf
|
|
|
2021 Corporate Sustainability Report
|
| |
https://www.fticonsulting.com/-/media/files/us-files/insights/reports/2022/dec/corporate-
sustainability-report-2021.pdf
|
|
|
Vendor Code of Conduct
|
| |
https://www.fticonsulting.com/~/media/Files/us-files/our-firm/guidelines/vendor-code-of-
conduct.pdf
|
|
|
■
|
| |
PROVIDE our NEOs with
competitive total pay opportunities to retain, motivate and attract talented executive officers.
|
|
|
■
|
| |
MAINTAIN continuity of
executive management by delivering opportunities for our CEO and other NEOs to earn competitive compensation.
|
|
|